E2F2 and malignant glioma: Consistent with our findings, Nakahata et al. demonstrated a tumorigenic role of E2F2 in vitro and in vivo, suggesting E2F2 is closely involved in gliomagenesis and may be a potential therapeutic target in malignant gliomas [38].